LOADING
ALLIANCE
01.

Global Alliance
of Clinical Research
Organizations

Diversity in Counsel,
Unity in Command

Twelve members across 95 countries provides you with access to 7500 study sites and an almost endless number of potential clinical trial subjects. Whether for small or mid-size Pharma and Biotech, the ACROSS Global CRO Alliance makes global studies seamless.

Learn More
Diversity in Counsel,
Unity in Command
02.
Cost Effective Solution
for Small and Mid-size
Pharma & Biotech
Situation

Pharma, Biotech and academia are constantly shifting their business models, seeking to access external innovation and enhance the value in medicinal products. Outdated R&D strategies are now being replaced by novel, more efficient approach to global clinical trials.

Target Audience

This is specifically true for small and mid-size sponsors which need to conduct global studies and do not have enough resources to manage multiple CROs and may not be able to afford global CRO services. In addition, such sponsors may lack the infrastructure, resources and expertise to manage their own international clinical trials.

Proposed Solution

ACROSS Global is an entirely new business model, providing enhanced and innovative global solutions through highly qualified, globally experienced, knowledgeable local experts. ACROSS Global identifies, analyses and mitigates risks across the entire clinical research spectrum, with an agility and focus to the envy of competitors. We provide value added solutions individually tailored for small and mid-size companies.

Schedule a Free Risk Assessment Now
solution
03.
Facts
& Figures
95
Countries
7,550
Sites
1,677
Employees
>25
Therapy
Areas
256
Ongoing
Studies
127,303
Patients
95
Countries
7,550
Sites
1,677
Employees
>25
Therapy
Areas
256
Ongoing
Studies
127,303
Patients
04.
Our Values
Excellence
We relentlessly pursue excellence
in everything we do, every day
Teamwork
We work together, across boundaries,
to meet the needs of our customers
Innovation
We embrace change, for ourselves
and for our customers and partners
Cultural Diversity
We embrace diversity as a competitive
advantage essential to our success
Simplicity
We constantly challenge processes,
procedures and activities that slow
us down or do not add value
Transparency
We communicate openly and build
relationships based on trust,
respect and caring
Submit for your Free Online Consultation
05.
ACROSS Global
Organizational Structure
Executive Committee
Steven Bukvic
Chairman of the Executive Committee, ACROSS
Chief Strategy Officer, Synergy Research Group
Steven Bukvic

Chief Strategy Officer

Synergy Research Group

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Christophe Tournerie
Founder and CEO, ClinActis
Christophe Tournerie

Founder and CEO of ClinActis Pte Ltd.

Dr Tournerie has more than 20 years’ experience in clinical research in Europe and Asia Pacific including Japan, working with biotechnology companies, pharmaceutical companies and clinical research organizations. After completion of his medical studies in Paris and various hospital assignments in France, Dr Tournerie spent a period of 3 years at the National Medical Research Institute in France in the field of drug development in anti-HIV products. His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology company developing anti-HIV products. Then, he moved to a global CRO, heading the Project management Department for South Europe, and then as Head of Operations in the Japan affiliate. Later, Dr Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical Company, based in Singapore.

Subsequently, Dr. Tournerie was Vice President Asia Pacific for a global CRO, based in Singapore. During this assignment, Dr Tournerie developed the business strategy for the region, successfully established and directed operations in 12 countries and built a highly professional team.

In 2009, Dr Tournerie founded ClinActis Pte Ltd, a full service CRO headquartered in Singapore and specialized in conducting clinical research in Asia Pacific, offering state of the art quality services, with cost effective solutions.

Dr Tournerie has acquired a vast and diverse experience in all key therapeutic areas as well as clinical trial phases (I to IV), with both large global and smaller scale studies in various geographical areas.

Georges Labaki
CEO, Phoenix CR
Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 14 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi-Aventis, Quintiles and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

Jahangir Hamid
COO, Rx Research
Jahangir Hamid

COO of Rx Research Pvt Ltd, a leading Pakistani CRO.

A pharmacist by training, Jahangir entered clinical research early on in his career. Starting off as a clinical pharmacist, Jahangir joined Rx Research as a director in 2010. During his time with Rx Research he has been involved in conducting and managing phase I to phase IV clinical trials in Pakistan. His expertise covers CVS, CNS, Metabolic, Infectious Diseases and Vaccines with Oncology, his major area of interest. Having worked with global pharmaceutical and CRO industry on multiple projects, he is very well versed with the regulatory, business, clinical and cultural requirements of Pakistan. He has led Rx to become the leading and fastest growing CRO in Pakistan.

Kálmán Törőcsik
COO, Research Professionals
Kálmán Törőcsik

Chief Operating Officer

Research Professionals

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Sule Mene
CEO, MENE HEALTH GROUP
Sule Mene

Sule is a clinical research professional.

She is a medical doctor pursued a Master’s degree of Business Administration at Harvard Business School.

As a young alumni, she first joined Merck Frost Centre in Canada and trained on clinical research in a place where research is the utmost priority. Throughout her career Sule held several research positions in different pharmaceutical companies international CROs including but not limited to ;

• Clinical Research Manager at MSD,

• Medical Manager and Clinical Research Manager at Abbott Laboratories,

• Country Manager at Ingenix

• International Project Manager at i3 Research,

• Head of Clinical Management in Lundbeck,

Sule is the founder of MENE RESEARCH, a contract research organization operating in Turkey which was established in 2002 (www.meneresearch.com) later on evolved to be Mene Health Group.

She also held several position in Not-For-Profit Organizations such as

• Founding member and the Board Member of the Association of Clinical Research in Turkey in 2006,

• Life Sciences Committee Co-chair, Licensing Executives Society (www.les- turkey.org) . She has also won the thropy of “Turkey’s Woman Entrepreneur of the Year award” in 2016.

Gabriel Veridze
CEO, Prometheus Biomedical
Gabriel Veridze

Cahaber Gabriel Veridze, MD, PH.D, SR CRA III is the founder and CEO of Prometheus Biomedical, Inc., a CRO based in Tbilisi, Georgia, running trials internationally ( in Georgia and the USA). He attended medical school in Tbilisi, Georgia, graduating in 1992. He performed his residency in Paris, Hamburg and Amsterdam before becoming an emergency room surgeon in Moscow. In 1995, he immigrated to Buenos Aires where he worked as a reconstructive plastic surgeon. Since moving to the USA in 2000, he has worked as a CR III for Novo Nordisk, Novella Clinical (a Quintiles company), GlaxoSmithKline, founded MedImperium, Atlantic Clinical Research Group, Inc. Prometheus Bio-Medical, and Millennium Clinical Research Group.

His clinical experience includes oncology, mental disorders, circulatory, respiratory, immunology, infections/parasitic diseases, endocrine/metabolic, musculoskeletal, central nervous system and digestive system trials.

He has been a member of the European Society of Clinical Microbiology and Infectious Diseases since 2004 and an Associate Member of the ACRP since 2011. He is fluent in English, Spanish, Russian and Georgian.

Cristina Morelli
Scientific Director, MTA
Cristina Morelli

Cristina Morelli graduated in Pharmacy in 1992; she has a Ph.D in Biotechnology and a Specialization in Clinical Pathology. After 13 years of laboratory research activity at international level in Italy, Germany, UK and USA, she moved on to clinical research field in 2005. In 2006 she started working as Project Manager in MTA where she became Scientific Director in 2012. Since then Cristina contributed in strengthening the company structure and in widening business areas both from geographical point of view and from clinical/scientific point of view, making MTA a reference partner not only for commercial sponsors but also for national and international academic sponsors.

Mariano Monteagudo
Director Strategy Development, ActivaCro
Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Busines Development Strategy in which he act as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries : Argentina, Chile,Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Charles Oviawe
Co-Founder and Managing Partner, Guosa Life Sciences
Charles Oviawe

Charles Oviawe is a Quality Assurance professional with over 20 year’s experience in Drug Development and Quality Systems Development and Management Auditing, with emphasis on the United States Food and Drug Administration, ICH and global requirements for GCP, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

With a Bachelor’s degree in Chemical Engineering, he held senior level Quality Assurance, Pharmaceutical Research and Development positions at Pfizer Corporate Headquarters in New York, Acadia Pharmaceuticals, Shionogi Inc. and Forest Laboratories in New York, USA. His extensive expertise includes global drug development encompassing Phase I to Phase IV programs in multiple therapeutic areas and Pre-approval inspection readiness activities.

Fredrik Hansson
Director Biometrics, CTC
Fredrik Hansson

Fredrik graduated with a M.Sc. in Statistics. Fredrik started his career in clinical research 30 years ago as a Biostatistician. Since then he held several positions such as:

• Senior biostatistician

• Head of biometrics

• Vice President

• Consultant

• Trainer

Today, Fredrik is the Director Biometrics, at Clinical Trial Consultants AB, which is specialised phase 0 to phase IIa CRO with 24 ICU beds.

Richard Tadd
Vice President of Global Business Development and Marketing, BCSC
Richard Tadd

Richard is an enthusiastic and goal-oriented young executive with over a 12 years’ experience in the China CRO industry. He is the Vice President of Global Business Development and Marketing at Beijing Clinical Service Center (BCSC), a full-service CRO, focused on assisting foreign companies enter the China market space.

After graduating from the University of Hertfordshire with a BSc. (Hons) Astrophysics in 2004, he left the UK to study Chinese Language and Culture at Shanghai International Studies University. After nearly 15 years in China he is fluent in both written and oral Mandarin and has a solid understanding of how Chinese people think and do business.

Whether you are considering China as part of your global development strategy, wondering how China can help you expedite your global development strategies or would like to learn more about how BCSC can help lower your costs whilst still delivering EMA/FDA- standard deliverables, you’ve come to the right place. Feel free to reach out to me for a consultation or cost proposal any time.

Steven Bukvic
Chairman of the Executive Committee, ACROSS
Chief Strategy Officer, Synergy Research Group
Steven Bukvic

Chief Strategy Officer

Synergy Research Group

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Christophe Tournerie
Founder and CEO, ClinActis
Christophe Tournerie

Founder and CEO of ClinActis Pte Ltd.

Dr Tournerie has more than 20 years’ experience in clinical research in Europe and Asia Pacific including Japan, working with biotechnology companies, pharmaceutical companies and clinical research organizations. After completion of his medical studies in Paris and various hospital assignments in France, Dr Tournerie spent a period of 3 years at the National Medical Research Institute in France in the field of drug development in anti-HIV products. His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology company developing anti-HIV products. Then, he moved to a global CRO, heading the Project management Department for South Europe, and then as Head of Operations in the Japan affiliate. Later, Dr Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical Company, based in Singapore.

Subsequently, Dr. Tournerie was Vice President Asia Pacific for a global CRO, based in Singapore. During this assignment, Dr Tournerie developed the business strategy for the region, successfully established and directed operations in 12 countries and built a highly professional team.

In 2009, Dr Tournerie founded ClinActis Pte Ltd, a full service CRO headquartered in Singapore and specialized in conducting clinical research in Asia Pacific, offering state of the art quality services, with cost effective solutions.

Dr Tournerie has acquired a vast and diverse experience in all key therapeutic areas as well as clinical trial phases (I to IV), with both large global and smaller scale studies in various geographical areas.

Georges Labaki
CEO, Phoenix CR
Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 14 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi-Aventis, Quintiles and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

Jahangir Hamid
COO, Rx Research
Jahangir Hamid

COO of Rx Research Pvt Ltd, a leading Pakistani CRO.

A pharmacist by training, Jahangir entered clinical research early on in his career. Starting off as a clinical pharmacist, Jahangir joined Rx Research as a director in 2010. During his time with Rx Research he has been involved in conducting and managing phase I to phase IV clinical trials in Pakistan. His expertise covers CVS, CNS, Metabolic, Infectious Diseases and Vaccines with Oncology, his major area of interest. Having worked with global pharmaceutical and CRO industry on multiple projects, he is very well versed with the regulatory, business, clinical and cultural requirements of Pakistan. He has led Rx to become the leading and fastest growing CRO in Pakistan.

Kálmán Törőcsik
COO, Research Professionals
Kálmán Törőcsik

Chief Operating Officer

Research Professionals

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Sule Mene
CEO, MENE HEALTH GROUP
Sule Mene

Sule is a clinical research professional.

She is a medical doctor pursued a Master’s degree of Business Administration at Harvard Business School.

As a young alumni, she first joined Merck Frost Centre in Canada and trained on clinical research in a place where research is the utmost priority. Throughout her career Sule held several research positions in different pharmaceutical companies international CROs including but not limited to ;

• Clinical Research Manager at MSD,

• Medical Manager and Clinical Research Manager at Abbott Laboratories,

• Country Manager at Ingenix

• International Project Manager at i3 Research,

• Head of Clinical Management in Lundbeck,

Sule is the founder of MENE RESEARCH, a contract research organization operating in Turkey which was established in 2002 (www.meneresearch.com) later on evolved to be Mene Health Group.

She also held several position in Not-For-Profit Organizations such as

• Founding member and the Board Member of the Association of Clinical Research in Turkey in 2006,

• Life Sciences Committee Co-chair, Licensing Executives Society (www.les- turkey.org) . She has also won the thropy of “Turkey’s Woman Entrepreneur of the Year award” in 2016.

Gabriel Veridze
CEO, Prometheus Biomedical
Gabriel Veridze

Cahaber Gabriel Veridze, MD, PH.D, SR CRA III is the founder and CEO of Prometheus Biomedical, Inc., a CRO based in Tbilisi, Georgia, running trials internationally ( in Georgia and the USA). He attended medical school in Tbilisi, Georgia, graduating in 1992. He performed his residency in Paris, Hamburg and Amsterdam before becoming an emergency room surgeon in Moscow. In 1995, he immigrated to Buenos Aires where he worked as a reconstructive plastic surgeon. Since moving to the USA in 2000, he has worked as a CR III for Novo Nordisk, Novella Clinical (a Quintiles company), GlaxoSmithKline, founded MedImperium, Atlantic Clinical Research Group, Inc. Prometheus Bio-Medical, and Millennium Clinical Research Group.

His clinical experience includes oncology, mental disorders, circulatory, respiratory, immunology, infections/parasitic diseases, endocrine/metabolic, musculoskeletal, central nervous system and digestive system trials.

He has been a member of the European Society of Clinical Microbiology and Infectious Diseases since 2004 and an Associate Member of the ACRP since 2011. He is fluent in English, Spanish, Russian and Georgian.

Cristina Morelli
Scientific Director, MTA
Cristina Morelli

Cristina Morelli graduated in Pharmacy in 1992; she has a Ph.D in Biotechnology and a Specialization in Clinical Pathology. After 13 years of laboratory research activity at international level in Italy, Germany, UK and USA, she moved on to clinical research field in 2005. In 2006 she started working as Project Manager in MTA where she became Scientific Director in 2012. Since then Cristina contributed in strengthening the company structure and in widening business areas both from geographical point of view and from clinical/scientific point of view, making MTA a reference partner not only for commercial sponsors but also for national and international academic sponsors.

Mariano Monteagudo
Director Strategy Development, ActivaCro
Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Busines Development Strategy in which he act as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries : Argentina, Chile,Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Charles Oviawe
Co-Founder and Managing Partner, Guosa Life Sciences
Charles Oviawe

Charles Oviawe is a Quality Assurance professional with over 20 year’s experience in Drug Development and Quality Systems Development and Management Auditing, with emphasis on the United States Food and Drug Administration, ICH and global requirements for GCP, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

With a Bachelor’s degree in Chemical Engineering, he held senior level Quality Assurance, Pharmaceutical Research and Development positions at Pfizer Corporate Headquarters in New York, Acadia Pharmaceuticals, Shionogi Inc. and Forest Laboratories in New York, USA. His extensive expertise includes global drug development encompassing Phase I to Phase IV programs in multiple therapeutic areas and Pre-approval inspection readiness activities.

Fredrik Hansson
Director Biometrics, CTC
Fredrik Hansson

Fredrik graduated with a M.Sc. in Statistics. Fredrik started his career in clinical research 30 years ago as a Biostatistician. Since then he held several positions such as:

• Senior biostatistician

• Head of biometrics

• Vice President

• Consultant

• Trainer

Today, Fredrik is the Director Biometrics, at Clinical Trial Consultants AB, which is specialised phase 0 to phase IIa CRO with 24 ICU beds.

Richard Tadd
Vice President of Global Business Development and Marketing, BCSC
Richard Tadd

Richard is an enthusiastic and goal-oriented young executive with over a 12 years’ experience in the China CRO industry. He is the Vice President of Global Business Development and Marketing at Beijing Clinical Service Center (BCSC), a full-service CRO, focused on assisting foreign companies enter the China market space.

After graduating from the University of Hertfordshire with a BSc. (Hons) Astrophysics in 2004, he left the UK to study Chinese Language and Culture at Shanghai International Studies University. After nearly 15 years in China he is fluent in both written and oral Mandarin and has a solid understanding of how Chinese people think and do business.

Whether you are considering China as part of your global development strategy, wondering how China can help you expedite your global development strategies or would like to learn more about how BCSC can help lower your costs whilst still delivering EMA/FDA- standard deliverables, you’ve come to the right place. Feel free to reach out to me for a consultation or cost proposal any time.

Management Boards
Standards
Office
Innovation &
Technology
Quality
Management
MEMBERSHIP COVERS
95 countries
ACTIVA
Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador, Uruguay

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

20

Employees

10

Ongoing Studies

169

Sites

2234

Patients

CTC
Sweden

Private Limited Liability Company “CTC” is a leading Swedish CRO. Founded in 2011, CTC is among industry’s most recognized brands in Sweden when considering phase 0 – phase IIa. CTC provides the full range of CRO services including its own clinic with 12 FIH beds and 24 phase I-IV beds.

53

Employees

19

Ongoing Studies

2

Sites

240

Patients

ClinActis
Australia, Hong Kong, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

+45

Employees

11

Ongoing Studies

+250

Sites

1,450

Patients

Beijing Clinical Service Center
China

Beijing Clinical Service Center (BCSC) is a full-service CRO. Headquartered in China and founded in 2009, BCSC has fast become one of the industry’s most recognized brands. With offices in 10 cities and hundreds of professionals nationwide, BCSC offers clients top-quality clinical services and access to all the leading clinical trial institutes China has to offer.

Employees

360

Ongoing Studies

103

Sites

6167

Patients

100, 776

Guosa Life Sciences
USA, Africa

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

8

Employees

2

Ongoing Studies

+44

Sites

+10,000

Patients

MENE
Armenia, Azerbaijan, Bosnia-Herzegovina, Croatia, Cyprus, Greece, Israel, Macedonia, Montenegro, Qatar, Serbia (incl Kosovo), Slovenia, Turkey, Uzbekistan, USA

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

54

Employees

15

On-going Studies

58

Sites

1,138

Patients

MTA
Austria, Belgium, France, Germany, Holland, Italy, Portugal, Spain, UK

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

21

Employees

16

On-going Studies

260

Sites

4,360

Patients

Phoenix
Egypt, Iran, Kuwait, Lebanon, Morroco, Oman, Tunisia, UAE

Phoenix CR is a Contract Research Organization (CRO) headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise.

Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

16

Employees

12

Ongoing Studies

+70

Sites

+4500

Patients

Prometheus
Georgia

Prometheus Bio-Medical is the CRO of choice for many Pharmaceutical, Biotech and Contract Research Organizations worldwide, offering a next-level clinical trial management experience. Our CRO covers Georgia as the most desirable country to conduct Clinical Trial due to its fastest start-up timeframe (max. 21 working day).

12

Employees

4

Ongoing Studies

17

Sites

330

Patients

Research Professionals
Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia

Research Professionals is a Hungary-based CRO founded in 2014. The company provides CRO services in Bulgaria, Czech Republic, Hungary, Romania, Slovakia and Poland. The company adds great value to the clinical trial conduct in region by providing a great variety of home care services.

8

Employees

10

Ongoing Studies

68

Sites

1,954

Patients

Rx Research
Pakistan

Rx Research is a Pakistan-based CRO founded in 2010. Rx Research not only provides it’s clients access to world class clinical trial centres in Pakistan, but also to the 5th largest patient population in the world (210 Million); with a built-in assurance of quality from a management team who have direct experience working in the European, North American and East Asian markets.

10

Employees

4

Ongoing Studies

30

Sites

500

Patients

Synergy Research Group
Canada, Lithuania, Belarus, Kazakhstan, Russia, Ukraine

Synergy Research Group is a leading Russia-based CRO. Founded in 2002, Synergy is among industry’s most recognized brands in Russia. With its unique prevolutionary mind-set, Synergy is now The World’s First Agile, Risk-Based CRO, innovative and technologically focused. Today, Synergy provides the full range of CRO services in Russia, Ukraine, Kazakhstan, Belarus, Lithuania and Canada.

110

Employees

56

Ongoing Studies

442

Sites

6,921

Patients

Top 5 CRO
in Ukraine 2018
in Ukraine 2018
Top 5 CRO
in Ukraine 2018
in Ukraine 2018
Across
Synergy Research Group
Russia

Synergy Research Group is a leading Russia-based CRO. Founded in 2002, Synergy is among industry’s most recognized brands in Russia. With its unique prevolutionary mind-set, Synergy is now The World’s First Agile, Risk-Based CRO, innovative and technologically focused. Today, Synergy provides the full range of CRO services in Russia, Ukraine, Kazakhstan, Belarus, Lithuania and Canada.

Top 5 CRO

in Russia 2016

Top 5 CRO

in Ukraine 2017

Synergy Research Group
Ukraine

Synergy Research Group is a leading Russia-based CRO. Founded in 2002, Synergy is among industry’s most recognized brands in Russia. With its unique prevolutionary mind-set, Synergy is now The World’s First Agile, Risk-Based CRO, innovative and technologically focused. Today, Synergy provides the full range of CRO services in Russia, Ukraine, Kazakhstan, Belarus, Lithuania and Canada.

Top 5 CRO

in Ukraine 2016

Top 5 CRO

in Russia 2017

CTC
Finland

Private Limited Liability Company “CTC” is a leading Swedish CRO. Founded in 2011, CTC is among industry’s most recognized brands in Sweden when considering phase 0 – phase IIa.
CTC provides the full range of CRO services including its own clinic with 12 FIH beds and 24 phase I-IV beds.

Fastest growing company

in Sweden 2015, 2016 and 2017 “Gasell”

Synergy Research Group
Kazakhstan

Synergy Research Group is a leading Russia-based CRO. Founded in 2002, Synergy is among industry’s most recognized brands in Russia. With its unique prevolutionary mind-set, Synergy is now The World’s First Agile, Risk-Based CRO, innovative and technologically focused. Today, Synergy provides the full range of CRO services in Russia, Ukraine, Kazakhstan, Belarus, Lithuania and Canada.

Top 5 CRO

in Ukraine 2018

Top 5 CRO

in Russia 2017

Beijing Clinical Service Center
China

MENE
Uzbekistan

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

Phoenix
Iran

Phoenix CR is a Contract Research Organization (CRO) headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise.

Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

Rx Research
Pakistan

Rx Research is a Pakistan-based CRO founded in 2010. Rx Research not only provides it’s clients access to world class clinical trial centres in Pakistan, but also to the 5th largest patient population in the world (210 Million); with a built-in assurance of quality from a management team who have direct experience working in the European, North American and East Asian markets.

4

Ongoing Studies

ClinActis
India

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Thailand

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Vietnam

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
South Korea

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Japan

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Taiwan

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Malaysia

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Indonesia

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Philippines

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
Australia

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

ClinActis
New Zealand

ClinActis Pte Ltd is a Clinical Research Organization (CRO) specialized in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

ClinActis Pte Ltd, founded in 2009 is headquartered in Singapore. Our regional coverage currently through our locally based staff includes Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Taiwan, Hong Kong, Australia/New Zealand and Korea. ClinActis is able to provide full-service solutions to support our clients with their clinical trials in Asia Pacific.

Red Herring Top 100 Asia winner

CTC
Sweden

Private Limited Liability Company “CTC” is a leading Swedish CRO. Founded in 2011, CTC is among industry’s most recognized brands in Sweden when considering phase 0 – phase IIa.
CTC provides the full range of CRO services including its own clinic with 12 FIH beds and 24 phase I-IV beds.

Fastest growing company

in Sweden 2015, 2016 and 2017 “Gasell”

CTC
Norway

Private Limited Liability Company “CTC” is a leading Swedish CRO. Founded in 2011, CTC is among industry’s most recognized brands in Sweden when considering phase 0 – phase IIa.
CTC provides the full range of CRO services including its own clinic with 12 FIH beds and 24 phase I-IV beds.

Fastest growing company

in Sweden 2015, 2016 and 2017 “Gasell”

Synergy
Lithuania

Synergy Research Group is a leading Russia-based CRO. Founded in 2002, Synergy is among industry’s most recognized brands in Russia. With its unique prevolutionary mind-set, Synergy is now The World’s First Agile, Risk-Based CRO, innovative and technologically focused. Today, Synergy provides the full range of CRO services in Russia, Ukraine, Kazakhstan, Belarus, Lithuania and Canada.

Top 5 CRO

in Russia 2016

Top 5 CRO

in Ukraine 2017

Synergy
Belarus

Synergy Research Group is a leading Russia-based CRO. Founded in 2002, Synergy is among industry’s most recognized brands in Russia. With its unique prevolutionary mind-set, Synergy is now The World’s First Agile, Risk-Based CRO, innovative and technologically focused. Today, Synergy provides the full range of CRO services in Russia, Ukraine, Kazakhstan, Belarus, Lithuania and Canada.

Top 5 CRO

in Russia 2016

Top 5 CRO

in Ukraine 2017

Research Professionals
Poland

Research Professionals is a Hungary-based CRO founded in 2014. The company provides CRO services in Bulgaria, Czech Republic, Hungary, Romania, Slovakia and Poland. The company adds great value to the clinical trial conduct in region by providing a great variety of home care services.

Top Home Care Research Nurse provider

in Hungary

Research Professionals
Romania

Research Professionals is a Hungary-based CRO founded in 2014. The company provides CRO services in Bulgaria, Czech Republic, Hungary, Romania, Slovakia and Poland. The company adds great value to the clinical trial conduct in region by providing a great variety of home care services.

Top Home Care Research Nurse provider

in Hungary

Research Professionals
Bulgaria

Research Professionals is a Hungary-based CRO founded in 2014. The company provides CRO services in Bulgaria, Czech Republic, Hungary, Romania, Slovakia and Poland. The company adds great value to the clinical trial conduct in region by providing a great variety of home care services.

Top Home Care Research Nurse provider

in Hungary

MENE
Turkey

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US ,Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

MENE
Armenia

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US ,Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

Prometheus
Georgia

Prometheus Bio-Medical is the CRO of choice for many Pharmaceutical, Biotech and Contract Research Organizations worldwide, offering a next-level clinical trial management experience. Our CRO covers Georgia as the most desirable country to conduct Clinical Trial due to its fastest start-up timeframe (max. 21 working day).

Phoenix
Saudi Arabia

Phoenix CR is a CRO headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise. Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

Phoenix
Oman

Phoenix CR is a Contract Research Organization (CRO) headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise.

Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

Phoenix
United Arab Emirates

Phoenix CR is a Contract Research Organization (CRO) headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise.

Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

Phoenix
Jordan

Phoenix CR is a CRO headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise. Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

Phoenix
Lebanon

Phoenix CR is a Contract Research Organization (CRO) headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise.

Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

MENE
Israel

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

MENE
Cyprus

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

MENE
Greece

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

MENE
Serbia & Montenegro

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

MENE
Macedonia

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

Research Professionals
Hungary

Research Professionals is a Hungary-based CRO founded in 2014. The company provides CRO services in Bulgaria, Czech Republic, Hungary, Romania, Slovakia and Poland. The company adds great value to the clinical trial conduct in region by providing a great variety of home care services.

Top Home Care Research Nurse provider

in Hungary

Research Professionals
Slovakia

Research Professionals is a Hungary-based CRO founded in 2014. The company provides CRO services in Bulgaria, Czech Republic, Hungary, Romania, Slovakia and Poland. The company adds great value to the clinical trial conduct in region by providing a great variety of home care services.

Top Home Care Research Nurse provider

in Hungary

Research Professionals
Czech Republic

Research Professionals is a Hungary-based CRO founded in 2014. The company provides CRO services in Bulgaria, Czech Republic, Hungary, Romania, Slovakia and Poland. The company adds great value to the clinical trial conduct in region by providing a great variety of home care services.

Top Home Care Research Nurse provider

in Hungary

MTA Group
Germany

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

CTC
Denmark

Private Limited Liability Company “CTC” is a leading Swedish CRO. Founded in 2011, CTC is among industry’s most recognized brands in Sweden when considering phase 0 – phase IIa.
CTC provides the full range of CRO services including its own clinic with 12 FIH beds and 24 phase I-IV beds.

Fastest growing company

in Sweden 2015, 2016 and 2017 “Gasell”

MTA Group
France

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MTA Group
Spain

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MTA Group
Portugal

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MTA Group
UK

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MTA Group
Italy

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MENE / Phoenix
Switzerland

MTA Group
Netherlands

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MTA Group
Belgium

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MTA Group
Austria

MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies and clinical research services. Our mission is to provide services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life. We work to provide excellent study data as quickly as possible through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with researchers and regulatory bodies.

16

Ongoing Studies

MENE
Croatia

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

MENE
Bosnia-Herzegovina

MENE RESEARCH, a Mene Health Group company, is a high profile Contract Research Organization  established in 2002 and HQs is located in Science-park of Gebze Organized Industrial Zone (GOSB) in Turkey, which is recognized as one of the most developed and modern organized industrial zones in the country. Currently the operation offices are available in US, Switzerland and Montenegro.

First approved CRO by MoH

in Turkey

Phoenix
Egypt

Phoenix CR is a CRO headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise. Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

13

Ongoing Studies

Phoenix
Algeria

Phoenix CR is a CRO headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise. Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

Phoenix
Morroco

Phoenix CR is a CRO headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise. Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

Phoenix
Tunisia

Phoenix CR is a CRO headquartered in Lebanon with representative offices in Egypt, Iran & Switzerland; specializing in both Interventional and Observational Clinical Trials. Phoenix CR’s key assets is that it combines the flexibility & responsiveness of its structure coupled with more than 14 years of international & regional expertise. Phoenix CR is continuously working on upgrading its systems, infrastructure, coverage area & designing new & innovative services in order to be the number one healthcare solution provider in the region.

12

Ongoing Studies

Guosa Life Sciences
Mali

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Nigeria

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Ghana

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Guinea

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Liberia

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Senegal

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Kenya

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Uganda

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Congo (Democratic Republic)

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Congo (Brazzaville)

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Gabon

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Tanzania

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Rwanda

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Angola

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Guosa Life Sciences
Malawi

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

+10,000

Patients

Guosa Life Sciences
South Africa

Guosa Life Sciences is a United States and Africa based specialty contract research organization with a focus on providing drug development lifecycle management solutions in emerging markets in Africa to pharmaceutical, biotechnology, medical device, academic, government and non-governmental organizations. Guosa Life Sciences provides the solutions a client needs to meet critical timelines and overcome the challenges of performing drug development activities in Sub-Saharan Africa.

Synergy
Canada

Synergy Research Group is a leading Russia-based CRO. Founded in 2002, Synergy is among industry’s most recognized brands in Russia. With its unique prevolutionary mind-set, Synergy is now The World’s First Agile, Risk-Based CRO, innovative and technologically focused. Today, Synergy provides the full range of CRO services in Russia, Ukraine, Kazakhstan, Belarus, Lithuania and Canada.

Top 5 CRO

in Russia 2016

Top 5 CRO

in Ukraine 2017

MENE / Prometheus / Synergy
USA

MENE / Prometheus / Synergy
USA

ACTIVA
Mexico

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Costa Rica

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Panama

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Brazil

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Peru

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Ecuador

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Colombia

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Argentina

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Uruguay

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

ACTIVA
Chile

ACTIVA CRO is a Regional Contract Research Organization operating in Latin America (South American CRO), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.

2234

Patients

Across
the Globe

Twelve members across 95 countries provides you with access to 7500 study sites and an almost endless number of potential clinical trial subjects. Whether for small or mid-size Pharma and Biotech, the ACROSS Global CRO Alliance makes global studies seamless.

Schedule a Free Online Consultation

Whether you are planning an entire clinical development plan, or perhaps just planning a single study, why not contact us for a free, no obligation consultation. With our expert team of clinical developers on hand, we can provide you with the best options to help you with the success of your project(s). Please complete the information below and we will contact you within one working day to schedule your consultation. We look forward to assisting you!

Schedule a Free Risk Assessment

If you planning on conducting a study, why not contact us for a free, no obligation risk assessment? With our expert team of clinical risk assessors on hand, we can help provide you with a key risk assessment to help ensure the success of your project. Please complete the information below and we will contact you within one working day to schedule your risk assessment consultation. We look forward to assisting you!

Schedule a Free Global Feasibility Assessment

If you’re planning a global study, whether Phase II-IV why not contact us for a free, no obligation global feasibility assessment? With our expert team of clinical developers on hand, we can provide you with the best options to help shape the best solutions for your global project. Please complete the information below and we will contact you within one working day to schedule your global feasibility assessment consultation. We look forward to assisting you!

Global Footprint

As a member of ACROSS, CROs gain exposure in new markets as their brand is extended to key regions of the world.

Brand Strengthening

With new countries and new services offered, the market position of each ACROSS member increases.

Cost Savings

ACROSS members also enjoy cost savings thanks to sharing resources and various overhead expenses, marketing etc.

Customer Benefits

Together, ACROSS members are fully committed to improving the customer experience. The A-Quality initiative offers a distinctively branded, consistent quality of clinical services throughout the alliance network.

Knowledge Sharing

By working together, member CROs can benefit from knowledge and best practice sharing, particularly when it comes to data quality, patient safety, customer service and operational efficiencies.

Join Us

If you are a CRO and operate in a country that is not shaded on the interactive map, and are interested in becoming an ACROSS Global member please complete and submit the information below. We will contact you within two business days.

Thank you
for your interest in ACROSS!

We will contact you within 24 hours.

Standards Office

ACROSS Global’s unique operating model allows our clients the opportunity to select the member companies and countries of their choice for the conduct of their clinical trial(s) whilst at the same time providing the assurance and confidence that their clinical trial(s) will be managed to the highest possible standards.
ACROSS Global’s “Standards Policy” defines the standards to which all ACROSS Global studies are managed. The Standards Policy covers all aspects of our operations and have been developed to meet the requirements of ICH-GCP E6 (R2), FDA Regulations, EMA Regulations as well as having been adapted where required to meet individual country regulations.
In addition to a single set of global Standard Operating Procedures (SOPs) covering our clinical monitoring, additional standards have also been put in place to ensure consistency of project management, training, and other processes and procedures that are performed on a global basis.

Innovation
& Technology
01.
Investigator Database
Shared feasibility database to accelerate site selection and avoid qualification duplication. Site Risk Ratings.
02.
Risk Based Monitoring
Shared Risk Assessment Tool(s) and Central Statistical Analysis Tool(s). Mitigation knowledge base.
03.
Blockchain
Evaluation and application of Blockchain technology to alliance operations. Smart contracts, ICF, CDA etc.
04.
Operational
Tools
Shared Project Management tools, EDC, eTMF, eCOA etc. Cloud-based document sharing compliant to CFR 21 Part 11.
Quality
Management

Quality Management is at the very heart of all aspects of ACROSS Globals’ work and deliverables. Quality Management oversight is ensured through the ACROSS Global Quality Management Governance Board (QMGB). Consisting of industry experienced senior executives and quality professionals, the QMGB is governed by a robust QMGB Charter which defines the governance of quality throughout the entire organization.
The implementation of a Standards Policy, and the adoption of a proprietary QMS Common Principles Grid (based on the industry’s recognized TransCelerate QMS Framework) combined with the control and oversight provided through the Quality Management Governance Board ensures ACROSS Global operates and delivers with a mindset of absolute quality for our clients.

ACROSS Global’s Successful Integration & Operation of TransCelerate’s Clinical Quality Management System (QMS) Framework